| Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. A D'Andrea, M Aste-Amezaga, NM Valiante, X Ma, M Kubin, G Trinchieri The Journal of experimental medicine 178 (3), 1041-1048, 1993 | 1765 | 1993 |
| Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. A D'Andrea, M Rengaraju, NM Valiante, J Chehimi, M Kubin, M Aste, ... The Journal of experimental medicine 176 (5), 1387-1398, 1992 | 1564 | 1992 |
| Human diversity in killer cell inhibitory receptor genes M Uhrberg, NM Valiante, BP Shum, HG Shilling, K Lienert-Weidenbach, ... Immunity 7 (6), 753-763, 1997 | 1307 | 1997 |
| Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors NM Valiante, M Uhrberg, HG Shilling, K Lienert-Weidenbach, KL Arnett, ... Immunity 7 (6), 739-751, 1997 | 906 | 1997 |
| Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells D Piccioli, S Sbrana, E Melandri, NM Valiante The Journal of experimental medicine 195 (3), 335-341, 2002 | 899 | 2002 |
| Nonviral delivery of self-amplifying RNA vaccines AJ Geall, A Verma, GR Otten, CA Shaw, A Hekele, K Banerjee, Y Cu, ... Proceedings of the National Academy of Sciences 109 (36), 14604-14609, 2012 | 713 | 2012 |
| Targeting the innate immune response with improved vaccine adjuvants A Pashine, NM Valiante, JB Ulmer Nature medicine 11 (Suppl 4), S63-S68, 2005 | 711 | 2005 |
| mTOR inhibition improves immune function in the elderly JB Mannick, G Del Giudice, M Lattanzi, NM Valiante, J Praestgaard, ... Science translational medicine 6 (268), 268ra179-268ra179, 2014 | 678 | 2014 |
| Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein S Crotta, A Stilla, A Wack, A D'Andrea, S Nuti, U D'Oro, M Mosca, ... The Journal of experimental medicine 195 (1), 35-42, 2002 | 620 | 2002 |
| Recent advances in the discovery and delivery of vaccine adjuvants DT O'Hagan, NM Valiante Nature Reviews Drug Discovery 2 (9), 727-735, 2003 | 586 | 2003 |
| New adjuvants for human vaccines ML Mbow, E De Gregorio, NM Valiante, R Rappuoli Current opinion in immunology 22 (3), 411-416, 2010 | 504 | 2010 |
| A cationic nanoemulsion for the delivery of next-generation RNA vaccines LA Brito, M Chan, CA Shaw, A Hekele, T Carsillo, M Schaefer, J Archer, ... Molecular Therapy 22 (12), 2118-2129, 2014 | 341 | 2014 |
| Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans SI Khakoo, R Rajalingam, BP Shum, K Weidenbach, L Flodin, DG Muir, ... Immunity 12 (6), 687-698, 2000 | 333 | 2000 |
| Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. NM Valiante, G Trinchieri The Journal of experimental medicine 178 (4), 1397-1406, 1993 | 276 | 1993 |
| NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection M Draghi, A Pashine, B Sanjanwala, K Gendzekhadze, C Cantoni, ... The Journal of Immunology 178 (5), 2688-2698, 2007 | 265 | 2007 |
| Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. JE Gumperz, LD Barber, NM Valiante, L Percival, JH Phillips, LL Lanier, ... Journal of immunology (Baltimore, Md.: 1950) 158 (11), 5237-5241, 1997 | 228 | 1997 |
| Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation G Trinchieri, M Wysocka, A D'Andrea, M Rengaraju, M Aste-Amezaga, ... Progress in growth factor research 4 (4), 355-368, 1992 | 221 | 1992 |
| Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis S Nuti, D Rosa, NM Valiante, G Saletti, M Caratozzolo, P Dellabona, ... European journal of immunology 28 (11), 3448-3455, 1998 | 212 | 1998 |
| Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus F Bagnoli, MR Fontana, E Soldaini, RPN Mishra, L Fiaschi, E Cartocci, ... Proceedings of the National Academy of Sciences 112 (12), 3680-3685, 2015 | 200 | 2015 |
| Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin‐12) on cell‐mediated cytotoxicity against tumor‐derived and virus‐infected cells J Chehimi, NM Valiante, A D'Andrea, M Rengaraju, Z Rosado, ... European journal of immunology 23 (8), 1826-1830, 1993 | 199 | 1993 |
